gdc

Endometrial Cancer

Drugs for Endometrial (Uterine) Cancer
Endometrial Cancer
Find financial assistance programs available for endometrial (uterine) cancer drugs.
Jemperli First Immunotherapy FDA Approved for Endometrial Cancer with dMMR Biomarker
Endometrial CancerFDA Approvals, News & UpdatesImmunotherapy
In April 2021, the FDA approved Jemperli (dostarlimab-gxly) for patients with recurrent or advanced endometrial cancer and the biomarker mismatch repair-deficient. This is the first immunotherapy approved for patients with this type of cancer.

Results 1 - 3 of 3

Subscribe to CONQUER: the patient voice magazine

Receive timely cancer news & updates, patient stories, and more.

Country
Gender
Race or Ethnicity
Profession or Role
Primary Interest